Connect
MJA
MJA

Pharmaceutical Preparations

Lessons from practice

A case of hepatitis attributable to repeated exposure to methoxyflurane during its use for procedural analgesia

Kacey M O’Rourke, Stuart McMaster and Karin M C Lust

Med J Aust 2011; 194 (8): 423-424 Free

Letters

Cough mixture dependence and stroke: implications for pseudoephedrine regulation

Ajay Bharatula and Peter W New

Med J Aust 2011; 194 (8): 427

Notable cases

Severe infection with Clostridium difficile PCR ribotype 027 acquired in Melbourne, Australia

Michael Richards, James Knox, Briony Elliott, Kate Mackin, Dena Lyras, Lynette J Waring and Thomas V Riley

Med J Aust 2011; 194 (7): 369-371 Free

Notable cases

Life-threatening hypokalaemia associated with ibuprofen-induced renal tubular acidosis

Jennifer L Ng, David J R Morgan, Nelson K M Loh, Seng K Gan, Patrick L Coleman, Gregory S Y Ong and David Prentice

Med J Aust 2011; 194 (6): 313-316 Free

Letters

Bipolar disorder supplement needed broader perspective

Jon N Jureidini, Peter I Parry, Catherine M Houen and Malcolm W Battersby

Med J Aust 2011; 194 (6): 326

Letters

Bipolar disorder supplement needed broader perspective

David J Castle, Michael Berk and Barbara M Hocking

Med J Aust 2011; 194 (6): 326

Conference report

Antibiotic resistance is an emerging threat to public health: an urgent call to action at the Antimicrobial Resistance Summit 2011

Thomas Gottlieb and Graeme R Nimmo

Med J Aust 2011; 194 (6): 281-283

Letters

A 2009 survey of psychotropic medication use in Sydney nursing homes

John Snowdon, Daniel Galanos and Divya Vaswani

Med J Aust 2011; 194 (5): 270-271

Letters

Use of mifepristone for medical abortion in Australia, 2006–2009

Caroline M de Costa

Med J Aust 2011; 194 (4): 206-207

Letters

Managing residual risk in patients receiving statin therapy

Brett H Forge

Med J Aust 2011; 194 (1): 54

Letters

Impact of adverse news media on prescriptions for osteoporosis: effect on fractures and mortality

Paul J Sambrook, B E Christopher Nordin and Alastair N Goss

Med J Aust 2011; 194 (1): 51-52

Letters

Managing residual risk in patients receiving statin therapy

Ian R Hamilton-Craig

Med J Aust 2011; 194 (1): 54

Letters

Impact of adverse news media on prescriptions for osteoporosis: effect on fractures and mortality

Philip N Sambrook, Jiang S Chen, Judy M Simpson and Lyn M March

Med J Aust 2011; 194 (1): 51-52

Letters

Expiry of patent protection on statins: effects on pharmaceutical expenditure in Australia

Steven R A Simoens

Med J Aust 2011; 194 (1): 52-54

Letters

Expiry of patent protection on statins: effects on pharmaceutical expenditure in Australia

Philip M Clarke and Edmund M Fitzgerald

Med J Aust 2011; 194 (1): 52-54

Letters

Managing residual risk in patients receiving statin therapy

Marilyn K Mann

Med J Aust 2011; 194 (1): 54

Book reviews

Creating and marketing illness

Greg Kyle

Med J Aust 2010; 193 (11): 708

Letters

Nebulised frusemide for the symptomatic treatment of end-stage congestive heart failure

Kate A Towers, Kimberley A Bardsley and Peter S Macdonald

Med J Aust 2010; 193 (9): 555

Supplement

Safer use of antimicrobials in hospitals: the value of antimicrobial usage data

Vicki McNeil, Marilyn Cruickshank and Margaret Duguid

Med J Aust 2010; 193 (8): S114 Free

Letters

Generic medicines literacy — minimising the potential for patient confusion

Linda V Graudins and Michael J Dooley

Med J Aust 2010; 193 (7): 427

Letters

Managing residual risk in patients receiving statin therapy

Brett D Montgomery

Med J Aust 2010; 193 (6): 375-376

Letters

Managing residual risk in patients receiving statin therapy

Ian R Hamilton-Craig

Med J Aust 2010; 193 (6): 375-376

Letters

Expiry of patent protection on statins: effects on pharmaceutical expenditure in Australia

Philip M Clarke and Edmund M FitzGerald

Med J Aust 2010; 193 (3): 186-187

Editorials

Rosiglitazone and cardiovascular disease revisited

Timothy M E Davis and Johannes B Prins

Med J Aust 2010; 193 (3): 134-135

Letters

Expiry of patent protection on statins: effects on pharmaceutical expenditure in Australia

Liliana Bulfone

Med J Aust 2010; 193 (3): 186-187